1.12
price down icon9.68%   -0.12
after-market 시간 외 거래: 1.08 -0.04 -3.57%
loading

Tscan Therapeutics Inc 주식(TCRX)의 최신 뉴스

pulisher
02:47 AM

TScan Therapeutics Shares Fall After BTIG Research Downgrade - MarketScreener

02:47 AM
pulisher
02:09 AM

Biotech firm TScan slashes jobs, extends cash runway amid strategic realignment - The Business Journals

02:09 AM
pulisher
08:49 AM

BTIG downgrades Tscan Therapeutics stock to Neutral on program delays By Investing.com - Investing.com Australia

08:49 AM
pulisher
08:25 AM

BTIG downgrades Tscan Therapeutics stock to Neutral on program delays - Investing.com India

08:25 AM
pulisher
08:23 AM

BTIG Research Downgrades TScan Therapeutics to Neutral From Buy - MarketScreener

08:23 AM
pulisher
07:03 AM

Needham Maintains TScan Therapeutics (TCRX) Buy Recommendation - Nasdaq

07:03 AM
pulisher
06:10 AM

TScan Therapeutics (TCRX) Analyst Update: Needham Lowers Price T - GuruFocus

06:10 AM
pulisher
05:21 AM

Reversal indicators forming on TScan Therapeutics Inc. stockQuarterly Profit Report & AI Enhanced Market Trend Forecasts - newser.com

05:21 AM
pulisher
04:00 AM

Applying chart zones and confluence areas to TScan Therapeutics Inc.Earnings Growth Report & Precise Swing Trade Entry Alerts - newser.com

04:00 AM
pulisher
03:57 AM

Best data tools to analyze TScan Therapeutics Inc. stockDollar Strength & Reliable Intraday Trade Alerts - newser.com

03:57 AM
pulisher
03:38 AM

How TScan Therapeutics Inc. stock reacts to global recession fears2025 Winners & Losers & Fast Entry High Yield Tips - newser.com

03:38 AM
pulisher
Nov 03, 2025

TScan to focus on heme program, cuts workforce by 30% amid FDA progress - Investing.com Nigeria

Nov 03, 2025
pulisher
Nov 03, 2025

Tscan Therapeutics stock plunges after pausing solid tumor trial enrollment By Investing.com - Investing.com UK

Nov 03, 2025
pulisher
Nov 03, 2025

Tscan Therapeutics stock plunges after pausing solid tumor trial enrollment - Investing.com

Nov 03, 2025
pulisher
Nov 03, 2025

Trend analysis for TScan Therapeutics Inc. this weekWatch List & Target Return Focused Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How TScan Therapeutics Inc. stock performs in rate cut cyclesRecession Risk & Low Risk Entry Point Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What technical models suggest about TScan Therapeutics Inc.’s comebackExit Point & Weekly Watchlist of Top Performers - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Using data filters to optimize entry into TScan Therapeutics Inc.Weekly Risk Report & High Yield Equity Trading Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

TScan Therapeutics Shifts Focus to Hematologic Malignancies - TipRanks

Nov 03, 2025
pulisher
Nov 03, 2025

TScan Therapeutics Announces Positive Phase I Meeting with FDA, Strategic Workforce Reduction, and Focus on Hematologic Malignancies - Quiver Quantitative

Nov 03, 2025
pulisher
Nov 03, 2025

TScan Therapeutics Announces 30% Workforce Reduction, Cash Runway Extension - TradingView

Nov 03, 2025
pulisher
Nov 03, 2025

TScan Therapeutics expects $2.3 million one-time charge for severance during 3 months ended Dec 31 - MarketScreener

Nov 03, 2025
pulisher
Nov 03, 2025

TScan Therapeutics Expects $2.3 Million One-Time Charge For Severance During 3 Months Ended Dec 31 - TradingView

Nov 03, 2025
pulisher
Nov 03, 2025

TScan Therapeutics (NASDAQ: TCRX) extends cash runway to H2 2027; cuts workforce about 30% - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

Technical signs of recovery in TScan Therapeutics Inc.Chart Signals & Stock Timing and Entry Methods - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Should you wait for a breakout in TScan Therapeutics Inc.Portfolio Risk Summary & Community Driven Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is TScan Therapeutics Inc. stock positioned well for digital economy2025 Winners & Losers & Free Community Supported Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is TScan Therapeutics Inc. building a consolidation base2025 Year in Review & Stock Timing and Entry Methods - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Can swing trading help recover from TScan Therapeutics Inc. lossesTrade Risk Summary & Comprehensive Market Scan Insights - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Can TScan Therapeutics Inc. stock maintain growth trajectoryEarnings Growth Report & Community Trade Idea Sharing - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is TScan Therapeutics Inc. still worth holding after the dipBull Run & Technical Pattern Recognition Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How TScan Therapeutics Inc. stock performs in high volatility marketsJuly 2025 Patterns & Risk Controlled Swing Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Applying sector rotation models to TScan Therapeutics Inc.Weekly Trade Recap & AI Based Buy/Sell Signal Reports - newser.com

Nov 02, 2025
$37.84
price up icon 1.45%
$28.76
price up icon 0.17%
$102.92
price up icon 1.33%
$104.83
price up icon 0.84%
biotechnology ONC
$309.19
price down icon 0.86%
$182.77
price down icon 1.86%
자본화:     |  볼륨(24시간):